Tenapanor

Generic Name
Tenapanor
Brand Names
Ibsrela
Drug Type
Small Molecule
Chemical Formula
C50H66Cl4N8O10S2
CAS Number
1234423-95-0
Unique Ingredient Identifier
WYD79216A6
Background

Tenapanor is a novel, small molecule medication approved in September 2019 for the treatment of constipation-predominant irritable bowel-syndrome (IBS-C). It was first designed and synthesized in 2012. As an inhibitor of the sodium/hydrogen exchanger isoform 3 (NHE3) transporter, it is the first and currently only medication within its class and therefore ex...

Indication

Tenapanor is indicated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) in adults.
...

Associated Conditions
Chronic Kidney Disease (CKD), Irritable Bowel Syndrome With Constipation (IBS-C)
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath